0
Article Tier 2 Gut & Microbiome Human Health Effects Remediation Sign in to save

WITHDRAWN: Degradation of PET microplastic particles to monomers in human serum by PETase

2023

AI summary Read the abstract

This paper has been withdrawn from publication. The study described testing PETase enzyme degradation of PET microplastics in human serum; however, as a retracted paper its findings should not be relied upon. (Note: a separate non-withdrawn version appears elsewhere in this database as ID 40206.)

Polymers
Models
Study Type In vitro

Abstract More than 8 bton of plastic waste has been generated posing severe environmental consequences and health risks. Due to prolonged exposure, microplastic particles are found in human blood and other bodily fluids. Despite a lack of toxicity studies regarding microplastics, harmful effects for humans seem plausible and cannot be excluded. As small plastic particles readily translocate from the gut to body fluids, enzyme-based treatment of serum could constitute a promising future avenue to clear synthetic polymers and their responding oligomers by their degradation into monomers of lower toxicity than the material they originate from. Still, whereas it is known that enzymatic depolymerization rate of synthetic polymers varies orders of magnitude depending on buffer and media composition, the activity of plastic degrading enzymes in serum was unknown. Here we report how an engineered PETase can expediently depolymerize crystalline microplastic-like particles of the commodity polymer polyethylene terephthalate (PET) into its non-toxic monomer terephthalic acid (TPA) alongside mono(2-hydroxyethyl) terephthalate (MHET) in human serum at 37°C. By developing an efficient method to depolymerize microplastics in vitro , our work takes a step closer to find a solution to the problem that microplastics in the bloodstream may pose in the future.

More Papers Like This

Article Tier 2

WITHDRAWN: Degradation of PET microplastic particles to monomers in human serum by PETase

AI summary Read the abstract

This record is marked as withdrawn from publication, indicating the study on degradation of PET microplastic particles to monomers in human serum has been retracted; no TLDR is generated for withdrawn publications.

Article Tier 2

Degradation of PET microplastic particles to monomers in human serum by PETase

AI summary Read the abstract

An engineered PETase enzyme broke crystalline PET microplastic-like particles down into their monomers in human serum at 37 °C. Enzyme activity in serum had not been measured before. The experiments were done in vitro.

Article Tier 2

Degradation of PET microplastic particles to monomers in human serum by designer enzymes

AI summary Read the abstract

Engineered PETase enzymes broke down PET microplastic-like particles into the monomer terephthalic acid in human serum at 37 °C. The experiments were done in vitro. The authors describe the result as a step toward future work on microplastics in blood.

Article Tier 2

Degradation of PET microplastic particles to monomers in human serum by PETase

AI summary Read the abstract

An engineered enzyme, PETase, broke down PET microplastic-like particles into terephthalic acid and a related compound in human serum at 37 °C. The enzyme did not affect cell viability in lab tests. The work was done in serum samples and cell cultures, not in living subjects.

Article Tier 2

Enzymatic Degradation of PET plastic

AI summary Read the abstract

This study tested commercial-grade enzymes for degrading PET plastic and found that enzymatic degradation was effective at laboratory scale but faced challenges for real-world application. Scaling up enzymatic PET recycling could reduce the persistence of plastic waste that eventually fragments into microplastics in the environment.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper